Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gerald Antoch

Showing results (361-370 of 443) with videos related to

Pageof 45
Sort By:
Tomography (Ann Arbor, Mich.)|June 1, 2022
Chemical Exchange Saturation Transfer for Lactate-Weighted Imaging at 3 T MRI: Comprehensive In Silico, In Vitro, In Situ, and In Vivo EvaluationsKarl Ludger Radke, Daniel B Abrar, Miriam Frenken, et al.
Journal of Clinical Medicine|March 29, 2023
Proof-of-Concept Double-Blind Placebo-Controlled Trial Measuring Cartilage Composition in Early Rheumatoid Arthritis under TNF-α-Inhibitor TherapyMiriam Frenken, Benedikt Ostendorf, Ralph Brinks, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 1, 2014
Comparison of 18F-FET PET and perfusion-weighted MR imaging: a PET/MR imaging hybrid study in patients with brain tumorsChristian P Filss, Norbert Galldiks, Gabriele Stoffels, et al.
Cancers|July 27, 2022
Lung Nodules Missed in Initial Staging of Breast Cancer Patients in PET/MRI-Clinically Relevant?Kai Jannusch, Nils Martin Bruckmann, Charlotte Johanna Geuting, et al.
European Urology Open Science|February 1, 2024
Magnetic Resonance Imaging-guided Active Surveillance Without Annual Rebiopsy in Patients with Grade Group 1 or 2 Prostate Cancer: The Prospective PROMM-AS StudyBirte Valentin, Christian Arsov, Tim Ullrich, et al.
Rofo : Fortschritte Auf Dem Gebiete Der Rontgenstrahlen Und Der Nuklearmedizin|March 1, 2019
Whole-Body [18F]-FDG-PET/MRI for Oncology: A Consensus RecommendationLale Umutlu, Thomas Beyer, Johannes Stefan Grueneisen, et al.
European Journal of Nuclear Medicine and Molecular Imaging|December 8, 2019
Non-invasive tumor decoding and phenotyping of cerebral gliomas utilizing multiparametric <sup>18</sup>F-FET PET-MRI and MR FingerprintingJohannes Haubold, Aydin Demircioglu, Marcel Gratz, et al.
European Urology|December 19, 2025
Risk-adapted Prostate Cancer Screening Achieves Mammography-like Benefits: Evidence and Implications for EuropeSigrid V Carlsson, Agne Krilaviciute, Rouvier Al-Monajjed, et al.
European Urology Open Science|January 21, 2026
Genetic Testing and Imaging in Men with Familial History or Genetic Predisposition of Prostate Cancer-Introducing the Prospective "ProFam-Risk" StudyJale Lakes, Matthias Boschheidgen, Gerald Antoch, et al.
Cancers|March 29, 2023
Correlation between Imaging Markers Derived from PET/MRI and Invasive Acquired Biomarkers in Newly Diagnosed Breast CancerKai Jannusch, Ann-Kathrin Bittner, Nils Martin Bruckmann, et al.
Pageof 45

Showing results (361-370 of 443) with videos related to

Sort By:
Pageof 45
Tomography (Ann Arbor, Mich.)|June 1, 2022
Chemical Exchange Saturation Transfer for Lactate-Weighted Imaging at 3 T MRI: Comprehensive In Silico, In Vitro, In Situ, and In Vivo EvaluationsKarl Ludger Radke, Daniel B Abrar, Miriam Frenken, et al.
Journal of Clinical Medicine|March 29, 2023
Proof-of-Concept Double-Blind Placebo-Controlled Trial Measuring Cartilage Composition in Early Rheumatoid Arthritis under TNF-α-Inhibitor TherapyMiriam Frenken, Benedikt Ostendorf, Ralph Brinks, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 1, 2014
Comparison of 18F-FET PET and perfusion-weighted MR imaging: a PET/MR imaging hybrid study in patients with brain tumorsChristian P Filss, Norbert Galldiks, Gabriele Stoffels, et al.
Cancers|July 27, 2022
Lung Nodules Missed in Initial Staging of Breast Cancer Patients in PET/MRI-Clinically Relevant?Kai Jannusch, Nils Martin Bruckmann, Charlotte Johanna Geuting, et al.
European Urology Open Science|February 1, 2024
Magnetic Resonance Imaging-guided Active Surveillance Without Annual Rebiopsy in Patients with Grade Group 1 or 2 Prostate Cancer: The Prospective PROMM-AS StudyBirte Valentin, Christian Arsov, Tim Ullrich, et al.
Rofo : Fortschritte Auf Dem Gebiete Der Rontgenstrahlen Und Der Nuklearmedizin|March 1, 2019
Whole-Body [18F]-FDG-PET/MRI for Oncology: A Consensus RecommendationLale Umutlu, Thomas Beyer, Johannes Stefan Grueneisen, et al.
European Journal of Nuclear Medicine and Molecular Imaging|December 8, 2019
Non-invasive tumor decoding and phenotyping of cerebral gliomas utilizing multiparametric <sup>18</sup>F-FET PET-MRI and MR FingerprintingJohannes Haubold, Aydin Demircioglu, Marcel Gratz, et al.
European Urology|December 19, 2025
Risk-adapted Prostate Cancer Screening Achieves Mammography-like Benefits: Evidence and Implications for EuropeSigrid V Carlsson, Agne Krilaviciute, Rouvier Al-Monajjed, et al.
European Urology Open Science|January 21, 2026
Genetic Testing and Imaging in Men with Familial History or Genetic Predisposition of Prostate Cancer-Introducing the Prospective "ProFam-Risk" StudyJale Lakes, Matthias Boschheidgen, Gerald Antoch, et al.
Cancers|March 29, 2023
Correlation between Imaging Markers Derived from PET/MRI and Invasive Acquired Biomarkers in Newly Diagnosed Breast CancerKai Jannusch, Ann-Kathrin Bittner, Nils Martin Bruckmann, et al.
Pageof 45